News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ex-Celgene Corporation (CELG), Sanofi-Aventis (New Jersey) (SAN.PA) Drug Execs Admit Roles in Stock Scheme



10/9/2013 9:04:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A former executive of Summit-based Celgene pharmaceuticals and another man have pleaded guilty to running an insider trading scheme. John Lazorchak was director of financial reporting at Celgene Corp., a biotech drugmaker. He and five other people were charged last November with participating in a five-year-long insider trading scheme.

Help employers find you! Check out all the jobs and post your resume.

Read at nj.com
Read at BusinessWeek
Read at Boston Globe
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES